SCHEMBL22751633

SCHEMBL22751633

Cc1ccc2c(c1)Sc1cc(C)ccc1N2c1cc2c3ccccc3n3c4ccccc4c(c1)c23

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 2/20 0.35
▸ MEN1 O00255 6/20 0.34
▸ KMT2A Q03164 6/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPT P10636 3/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ NOX1 Q9Y5S8 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ HTT P42858 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ HPGD P15428 2/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22751701 0.84 HDAC6 (0.39) DRD3MEN1KMT2AMAPTNOX1
SCHEMBL22751634 0.84 — —
SCHEMBL22751698 0.81 BCHE (0.31) MAPTBCHEACHELMNAHTT
SCHEMBL22751640 0.80 MAPT (0.36) MEN1KMT2AMAPTBCHEACHE
SCHEMBL22751659 0.80 BCHE (0.30) MAPTBCHEACHELMNAHTT
SCHEMBL22751642 0.77 — —
SCHEMBL22751638 0.77 PKM (0.34) MAPT
SCHEMBL20689998 0.76 KDM4E (0.31) KDM4EALDH1A1ATMHSD17B10L3MBTL1
SCHEMBL22751660 0.76 — —
SCHEMBL12433671 0.76 MEN1 (0.43) DRD3MEN1KMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10862050-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10862050-B2 Heterocyclic compound and organic electroluminescence device including the same CCNT1, CCNL2, CCNA1 DRD3 1457/4885MEN1 345/4885KMT2A 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback